Northwest Biotherapeutics Inc (NASDAQ:NWBO)

9.63
Delayed Data
As of Jun 29
 -0.28 / -2.83%
Today’s Change
3.79
Today|||52-Week Range
10.79
+80.00%
Year-to-Date
No recent news for Northwest Biotherapeutics Inc.

Today’s Trading

Previous close9.91
Today’s open9.81
Day’s range-- - --
Volume728,696
Average volume (3 months)607,680
Market cap$740.4M
Dividend yield--
Data as of 06/29/2015

Growth & Valuation

Earnings growth (last year)-14.50%
Earnings growth (this year)--
Earnings growth (next 5 years)+10.00%
Revenue growth (last year)+79.73%
P/E ratioNM
Price/Sales218.00
Price/Book--

Competitors

 Today’s
change
Today’s
% change
SCMPSucampo Pharmaceutic...+0.04+0.25%
RVNCRevance Therapeutics...-1.26-3.84%
SGNTSagent Pharmaceutica...-0.60-2.44%
AMPHAmphastar Pharmaceut...-0.57-3.18%
Data as of 06/29/2015

Financials

Last reporting date--
EPS forecast (this quarter)--
Annual revenue (last year)$1.5M
Annual profit (last year)-$135.6M
Net profit margin-9,328.34%

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman, President, CEO, CFO &
CAO
Linda F. Powers
Chief Scientific Officer, Secretary &
Director
Alton L. Boynton
Corporate headquarters
Bethesda, Maryland

Forecasts

To view my watchlist

Not a member yet?

Sign up now for a free account

Partner Financial Offers